- Home
- TRNS vs TRVI Comparison
TRNS vs TRVI Comparison
Compare TRNS & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- TRVI
- Stock Information
- Founded
- TRNS 1964
- TRVI 2011
- Country
- TRNS United States
- TRVI United States
- Employees
- TRNS N/A
- TRVI N/A
- Industry
- TRNS Electrical Products
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- TRNS Industrials
- TRVI Health Care
- Exchange
- TRNS Nasdaq
- TRVI Nasdaq
- Market Cap
- TRNS 748.7M
- TRVI 629.8M
- IPO Year
- TRNS N/A
- TRVI 2019
- Fundamental
- Price
- TRNS $87.38
- TRVI $6.51
- Analyst Decision
- TRNS Buy
- TRVI Strong Buy
- Analyst Count
- TRNS 4
- TRVI 8
- Target Price
- TRNS $108.67
- TRVI $19.31
- AVG Volume (30 Days)
- TRNS 139.6K
- TRVI 1.0M
- Earning Date
- TRNS 05-19-2025
- TRVI 05-08-2025
- Dividend Yield
- TRNS N/A
- TRVI N/A
- EPS Growth
- TRNS N/A
- TRVI N/A
- EPS
- TRNS 1.57
- TRVI N/A
- Revenue
- TRNS $278,421,000.00
- TRVI N/A
- Revenue This Year
- TRNS $11.73
- TRVI N/A
- Revenue Next Year
- TRNS $5.05
- TRVI N/A
- P/E Ratio
- TRNS $55.66
- TRVI N/A
- Revenue Growth
- TRNS 7.30
- TRVI N/A
- 52 Week Low
- TRNS $67.56
- TRVI $2.30
- 52 Week High
- TRNS $147.12
- TRVI $7.39
- Technical
- Relative Strength Index (RSI)
- TRNS 55.43
- TRVI 54.36
- Support Level
- TRNS $88.46
- TRVI $6.08
- Resistance Level
- TRNS $93.77
- TRVI $6.47
- Average True Range (ATR)
- TRNS 4.00
- TRVI 0.34
- MACD
- TRNS 0.33
- TRVI -0.02
- Stochastic Oscillator
- TRNS 47.96
- TRVI 67.01
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.